Keywords
drug resistant
gram-negative
hospital-acquired infection
MRSA
VRE
Abstract
Multidrug resistant pathogens are a widespread problem in the hospital setting especially on intensive care units (ICU). This study evaluated the susceptibility of clinical isolates of gram-negative extensively drug resistant (XDR) organisms, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE) to a proprietary chlorhexidine digluconate (CHG) formulation used in one brand of CHG-impregnated cloths. Ten isolates each of XDR Pseudomonas aeruginosa, XDR Acinetobacter baumannii, XDR Klebsiella pneumoniae, XDR Escherichia coli, MRSA, and vancomycin-resistant Enterococcus faecium from our hospital were tested. All isolates were susceptible to the proprietary CHG formulation (0.5%, 1%, 2%), with 99% to 100% suppression of growth at the earliest time point in time kill assays (1 minute for gram-positive and 15 seconds for gram-negative organisms). Minimum inhibitory concentrations ranged from 1:4096 to 1:65536 for MRSA, 1:1024 to 1:2048 for VRE, 1:2048 to 1:4096 for XDR .E. coli, 1:512 to 1:2048 for XDR A. baumannii, 1:512 to 1:1024 for XDR P. aeruginosa, and 1:512 to 1:1024 for XDR K. pneumoniae. Cloths impregnated with this CHG formulation provide effective protection against colonization and infection by many pathogens. This study provides in vitro evidence that the proprietary CHG formulation used in one brand of CHG-impregnated cloths is effective against XDR gram-negative organisms, MRSA, and VRE.
References
Luyt CE. Bréchot, N., Trouillet, J.-L., et al. Antibiotic stewardship in the intensive care unit. Critical Care 2014;18(5):480-91. Available from: http://ccforum.com/content/18/5/480 doi: 10.1186/s13054-014-0480-6. [Google Scholar]
Sievert D. M., Ricks, P., Edwards, J.R., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013;34(01):1-14. Available from: http://www.journals.cambridge.org/abstract_S0195941700031921 doi: 10.1086/668770. [Google Scholar]
Mutters N. T., Mersch-Sundermann, V., Mutters, R., et al. Control of the spread of vancomycin-resistant Enterococci in hospitals: epidemiology and clinical relevance. Dtsch Arztebl Int 2013;110(43):725-31. [Google Scholar]
Nelson M. U., Bizzarro, M..J., Dembry, L.M., et al. One size does not fit all: Why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. J Perinatol 2014;34(9):653-5. Available from: http://www.nature.com/doifinder/10.1038/jp.2014.125 doi: 10.1038/jp.2014.125. [Google Scholar]
Schwab F. Meyer, E., Geffers, C., et al. Understaffing, overcrowding, inappropriate nurse: ventilated patient ratio and nosocomial infections: which parameter is the best reflection of deficits. J Hosp Infect 2012;80(2):133-9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S019567011100449X doi: 10.1016/j.jhin.2011.11.014. [Google Scholar]
Cheah AL, Spelman T, Liew D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19:E181–E189. PubMed PMID: 23398607. doi:10.1111/1469-0691.12132.
Lambert M. L., Suetens, C., Savey, A., et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011;11(1):30-8. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1473309910702589 doi: 10.1016/S1473-3099(10)70258-9. [Google Scholar]
Mattner F. Bange, F-C., Meyer, E., et al. Preventing the spread of multidrug-resistant gram-negative pathogens. Dtsch Arztebl Int 2012;108:39-45. [Google Scholar]
Climo M. W., Yokoe, D. S., Warren, D. K., et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368(6):533-42. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1113849 doi: 10.1056/NEJMoa1113849. [Google Scholar]
Huang S. S., Septimus E., Avery T.R., et al. Cost savings of universal decolonization to prevent intensive care unit infection: Implications of the REDUCE MRSA Trial. Infect Control Hosp Epidemiol 2014;35. PubMed PMID: 25222894. doi: 10.1086/677819. [Google Scholar]
Edmiston JC. E., Krepel, C.J., Seabrook, G.R., et al. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission. J Am Coll Surg 2008;207(2):233-9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1072751508001774 doi: 10.1016/j.jamcollsurg.2007.12.054. [Google Scholar]
Huang S. S., Septimus, E., Kleinman, K., et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013;368(24):2255-65. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1207290 doi: 10.1056/NEJMoa1207290. [Google Scholar]
Milstone A. M., Elward, A., Song, X., et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet Infect Dis 2013;381(9872):1099-106. [Google Scholar]
Vernon MO, Hayden, M . K., Trick, W.E., et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166:306-12. [Google Scholar]
Derde L. P.G., Dautzenberg, M.J.D., Bonten, M.J.M. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 2012;38(6):931-9. Available from: http://link.springer.com/10.1007/s00134-012-2542-z doi: 10.1007/s00134-012-2542-z. [Google Scholar]
Cassir N. Papazian, L., Fournier, P.E., et al. Insights into bacterial colonization of intensive care patients' skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis 2015;34(5):999-1004. Available from: http://link.springer.com/10.1007/s10096-015-2316-y doi: 10.1007/s10096-015-2316-y. [Google Scholar]
17. Cassir N, Thomas G, Hraiech S, et al. Chlorhexidine daily bathing: Impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control. 2015 doi: 101016/ jajic201502010 (Epub ahead of print)
Magiorakos A. P., Srinivasan, A., Carey, R. B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18(3):268-81. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1198743X14616323 doi: 10.1111/j.1469-0691.2011.03570.x. [Google Scholar]
Gebel J, Werner HP, Kirsch-Altena A, et al. Standardmethoden der DGHM zur Prüfung chemischer Desinfektionsverfahren. Berlin: MHP Verlag; 2001. [Google Scholar]
Umscheid C. A., Mitchell, M.D., Doshi, J.A., et al. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32(02):101-14. Available from: http://www.journals.cambridge.org/abstract_S0195941700039801 doi: 10.1086/657912. [Google Scholar]
Quach C. Milstone, A.M., Perpête, C., et al. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2014;35(02):158-63. Available from: http://www.journals.cambridge.org/abstract_S0195941700035001 doi: 10.1086/674862. [Google Scholar]
Cookson B. D., Bolton, M.C., Platt, J.H. Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrobial Agents Chemother 1991;35(10):1997-2002. Available from: http://aac.asm.org/cgi/doi/10.1128/AAC.35.10.1997 doi: 10.1128/AAC.35.10.1997. [Google Scholar]